Eurofins Scientific: share up with analyst's backing

(CercleFinance.com) - Eurofins Scientific shares rose on Tuesday in Paris, boosted by positive comments from Barclays analysts.


In its morning comment, the British bank points out that both Q3 results and the group's recent investor day highlighted progress in pricing and an increased focus on profit margins in Europe.

"Despite its share price volatility, Eurofins is a durable & defensive business we see capable
of delivering mid teens TSR over the next few years", Barclays says.

While it reiterates its "overweight" recommendation on the stock, Barclays has actually reduced its target price for them to E60, from E70 previously.

At lunchtime, the bio-analysis specialist's share was up 0.7%, although is still down 25% YTD.


Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.